Related Experiment Video
Updated: Nov 18, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Pre-operative heart failure worsens outcome after aortic valve replacement irrespective of left ventricular ejection
Maria Thilén1, Stefan James1,2, Elisabeth Ståhle3
1Department of Medical Sciences, Cardiology, Uppsala University, Akademiska sjukhuset, 751 85, Uppsala, Sweden.
Insights
A history of heart failure or atrial fibrillation worsens outcomes after aortic valve replacement, regardless of left ventricular ejection fraction. These conditions may indicate underlying issues not captured by LVEF alone, suggesting a need for revised timing strategies for AVR.
Area of Science:
- Cardiology
- Cardiac Surgery
- Clinical Prognostics
Background:
- Left ventricular ejection fraction (LVEF) is a key factor influencing outcomes after aortic valve replacement (AVR) for aortic stenosis (AS).
- The prognostic value of co-existing cardiovascular diseases relative to pre-operative LVEF in AS patients undergoing AVR requires further investigation.
Purpose of the Study:
- To assess the prognostic significance of pre-operative heart failure (HF) and atrial fibrillation (AF) in patients undergoing AVR for AS.
- To determine if these conditions impact outcomes differently based on preserved or reduced LVEF.
Main Methods:
- Analysis of a national heart disease register for adult patients undergoing AVR for AS between 2008-2014.
- Utilized Cox regression to analyze all-cause mortality and heart failure hospitalization post-AVR, stratified by LVEF (preserved vs. reduced ≤50%).
Main Results:
- 10,406 patients were included (median age 73 years, follow-up 35 months); 72.2% had preserved LVEF.
- Pre-operative HF increased mortality risk irrespective of LVEF (HR 1.64 and 1.58).
- Prior AF increased mortality risk with preserved LVEF (HR 1.62) but not reduced LVEF (HR 1.05). Both HF and AF increased post-operative HF hospitalization risk.
Conclusions:
- Pre-operative HF and AF negatively impact post-operative prognosis in AVR patients, irrespective of LVEF.
- HF and AF may serve as indicators of myocardial fibrosis not detected by LVEF, suggesting LVEF alone is suboptimal for timing AVR.
- These findings highlight the importance of considering comorbidities beyond LVEF for optimizing AVR timing and patient management.
Aims:
Left ventricular ejection fraction (LVEF) affects the outcome of aortic valve replacement (AVR) in aortic stenosis (AS). The study aim was to investigate the prognostic importance of concomitant cardiovascular disease in relation to pre-operative LVEF.
Methods And Results:
All adult patients undergoing AVR due to AS 2008-14 in a national register for heart diseases were included. All-cause mortality and hospitalization for heart failure during follow-up after AVR, stratified by preserved or reduced LVEF (≤50%), were derived from national patient registers and analysed by Cox regression. During the study period, 10 406 patients, median age 73 years, a median follow-up of 35 months were identified. Preserved LVEF was present in 7512 (72.2%). Among them, 647 (8.6%) had a history of heart failure (HF) and 1099 (14.6%) atrial fibrillation (AF) before the intervention. Pre-operative HF was associated with higher mortality irrespective of preserved or reduced LVEF: hazard ratio (HR) 1.64 [95% confidence interval (CI) 1.35-1.99] and 1.58 (95% CI 1.30-1.92). Prior AF was associated with a higher risk of mortality in patients with preserved but not in those with reduced LVEF: HR 1.62 (95% CI 1.36-1.92) and 1.05 (95% CI 0.86-1.28). Irrespective of LVEF, pre-operative HF and AF were associated with an increased risk of post-operative heart failure hospitalization.
Conclusion:
In patients planned for AVR, a history of HF or AF, irrespective of LVEF, worsens the post-operative prognosis. Heart failure and AF can be seen as markers of myocardial fibrosis not necessarily discovered by LVEF and the merely use of it, besides symptoms, for the timing of AVR seems suboptimal.
Related Concept Videos
Pathophysiology of Heart Failure
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Heart Failure II: Pathophysiology
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction

